000 01202 a2200277 4500
005 20250514162211.0
264 0 _c20040106
008 200401s 0 0 eng d
022 _a1198-743X
024 7 _a10.1046/j.1469-0691.2003.00734.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGoldstein, F W
245 0 0 _aVancomycin-resistant Staphylococcus aureus: no apocalypse now.
_h[electronic resource]
260 _bClinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
_cAug 2003
300 _a761-5 p.
_bdigital
500 _aPublication Type: Editorial
650 0 4 _aDrug Therapy, Combination
_xpharmacology
650 0 4 _aHumans
650 0 4 _aStaphylococcus aureus
_xdrug effects
650 0 4 _aTeicoplanin
_xpharmacology
650 0 4 _aVancomycin
_xblood
650 0 4 _aVancomycin Resistance
700 1 _aKitzis, M D
773 0 _tClinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
_gvol. 9
_gno. 8
_gp. 761-5
856 4 0 _uhttps://doi.org/10.1046/j.1469-0691.2003.00734.x
_zAvailable from publisher's website
999 _c14353715
_d14353715